{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:22:20Z","timestamp":1773872540112,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ygyno.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T14:50:18Z","timestamp":1532443818000},"page":"501-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin A.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2252-3577","authenticated-orcid":false,"given":"Hiroko","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.07.016_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0010","author":"National Cancer Institute"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinthera.2014.11.013","article-title":"Cervical cancer survivorship: long-term quality of life and social support","volume":"37","author":"Pfaendler","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L","article-title":"Second primary cancer after treatment for cervical cancer. An international cancer registries study","volume":"76","author":"Kleinerman","year":"1995","journal-title":"Cancer"},{"issue":"283","key":"10.1016\/j.ygyno.2018.07.016_bb0030","first-page":"e1","article-title":"Smoking behavior in women with locally advanced cervical carcinoma: a Gynecologic Oncology Group study","volume":"202","author":"Waggoner","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181156","article-title":"Integrating cervical cancer with HIV healthcare services: a systematic review","volume":"12","author":"Sigfrid","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0045","series-title":"Handbook of Gynecology","first-page":"789","article-title":"Diagnosis and management of vulvar cancer","volume":"1","author":"Shindo","year":"2017"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0050","first-page":"221","article-title":"The immune microenvironment and HPV in anal cancer: rationale to complement chemoradiation with immunotherapy","volume":"2017","author":"Martin","year":"1868","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ogc.2013.03.003","article-title":"Vulvar and vaginal HPV disease","volume":"40","author":"Nelson","year":"2013","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0060","unstructured":"The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, https:\/\/seer.cancer.gov\/ (accessed 6\/11\/2018)."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0065","author":"National Cancer Registrars Association"},{"issue":"580","key":"10.1016\/j.ygyno.2018.07.016_bb0070","article-title":"Risk of metachronous ovarian cancer after ovarian conservation in young women with stageIcervical cancer","volume":"217","author":"Matsuo","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/AOG.0000000000002142","article-title":"Risk of subsequent ovarian cancer after ovarian conservation in young women with stageIendometrioid endometrial cancer","volume":"130","author":"Matsuo","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(82)90514-4","article-title":"Subsequent malignancies associated with carcinoma of the uterine cervix: including an analysis of the effect of patient and treatment parameters on incidence and sites of metachronous malignancies","volume":"8","author":"Kapp","year":"1982","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0085","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0000000000001754","article-title":"Ovarian conservation and overall survival in young women with early-stage cervical cancer","volume":"129","author":"Matsuo","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0095","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejso.2017.01.017","article-title":"Significance of uterine corpus tumor invasion in early-stage cervical cancer","volume":"43","author":"Matsuo","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc. Ser. B Stat Methodol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0115","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/cncr.23746","article-title":"Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors","volume":"113","author":"Balamurugan","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0090-8258(03)00231-2","article-title":"Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England","volume":"90","author":"Evans","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/gyno.1996.4551","article-title":"Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985-1992","volume":"64","author":"Fisher","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00001648-200007000-00016","article-title":"Second primary cancer after in situ and invasive cervical cancer","volume":"11","author":"Hemminki","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0135","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4143\/crt.2014.326","article-title":"Second primary cancer after diagnosis and treatment of cervical cancer","volume":"48","author":"Lim","year":"2015","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ypmed.2016.06.041","article-title":"Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: a population-based study","volume":"90","author":"Neumann","year":"2016","journal-title":"Prev. Med."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9378(87)80148-5","article-title":"Multiple primary gynecologic neoplasms","volume":"157","author":"Rose","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0150","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/AOG.0b013e31820bfb16","article-title":"Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm","volume":"117","author":"Saleem","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0155","first-page":"765","article-title":"Second lower genital tract squamous cell carcinoma following cervical cancer. A clinical study of 46 patients","volume":"79","author":"Senkus","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/bjc.1988.96","article-title":"Multiple primary tumours in women with vulvar neoplasms: a case-control study","volume":"57","author":"Sherman","year":"1988","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0165","series-title":"Handbook of Gynecology","first-page":"969","article-title":"Preinvasive epithelial disorders of the vulvar","volume":"1","author":"Moeini","year":"2017"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2009.06.002","article-title":"The role of immunity in elderly cancer","volume":"74","author":"Malaguarnera","year":"2009","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0175","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s12032-014-0943-2","article-title":"Risk of colorectal cancer among long-term cervical cancer survivors","volume":"31","author":"Rodriguez","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0180","author":"National Comprehensive Cancer Network Clinical Practice Guideline in Oncology"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0185","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/AOG.0b013e31819fe844","article-title":"Factors affecting risk of mortality in women with vaginal cancer","volume":"113","author":"Shah","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0190","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ijc.30821","article-title":"Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva","volume":"141","author":"Faber","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.07.016_bb0195","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","article-title":"Pathology and epidemiology of HPV infection in females","volume":"117","author":"Stanley","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2012.01.012","article-title":"Prognostic significance of adenocarcinoma histology in women with cervical cancer","volume":"125","author":"Galic","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/AOG.0b013e3181954c5b","article-title":"Radiation-associated endometrial cancer","volume":"113","author":"Kumar","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0210","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ejca.2008.11.030","article-title":"Multiple tumours in survival estimates","volume":"45","author":"Rosso","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2018.07.016_bb1000","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO)","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2018.07.016_bb0220","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818310801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818310801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T15:42:05Z","timestamp":1720453325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818310801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0090825818310801"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.07.016","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}